These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25056847)

  • 1. Expressional changes of genes and miRNA in common megakaryocyte-erythroid progenitors from lower-risk myelodysplastic syndrome.
    Maki K; Sasaki K; Nagata Y; Nagasawa F; Nakamura Y; Ogawa S; Mitani K
    Int J Hematol; 2014 Oct; 100(4):361-9. PubMed ID: 25056847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Short Variant Form of New Kelch Family Protein Leads to Erythroid and Megakaryocyte Dysplasia by Targeting Megakaryocyte-Erythroid Progenitors.
    Lin Y; Luo Y; Hu F; Wang T; Dong Y; Yang D; He X; Chen X; Wang J; Du J; Zhang X
    DNA Cell Biol; 2018 Oct; 37(10):831-838. PubMed ID: 30124330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD.
    Claessens YE; Park S; Dubart-Kupperschmitt A; Mariot V; Garrido C; Chrétien S; Dreyfus F; Lacombe C; Mayeux P; Fontenay M
    Blood; 2005 May; 105(10):4035-42. PubMed ID: 15677568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
    Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
    Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.
    Kuang X; Chi J; Wang L
    Hematology; 2016 Dec; 21(10):593-602. PubMed ID: 27357100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis.
    Raimbault A; Pierre-Eugene C; Rouquette A; Deudon C; Willems L; Chapuis N; Mathis S; Kunz C; Fricke H; Kosmider O; Bardet V; Fontenay M;
    Oncotarget; 2016 Mar; 7(12):14898-911. PubMed ID: 26910909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre.
    Huang H; Xu C; Gao J; Li B; Qin T; Xu Z; Ren S; Zhang Y; Jiao M; Qu S; Pan L; Hu N; Liu J; Cai W; Zhang Y; Wu D; Zhang P; Gale RP; Huang G; Zhou J; Shi L; Xiao Z
    Blood Cancer J; 2020 Aug; 10(8):83. PubMed ID: 32801296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.
    Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z
    Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High erythroferrone expression in CD71
    Riabov V; Mossner M; Stöhr A; Jann JC; Streuer A; Schmitt N; Knaflic A; Nowak V; Weimer N; Obländer J; Palme I; Schumann C; Baldus CD; Schulze TJ; Wuchter P; Röhl H; Jawhar A; Weiss C; Boch T; Metzgeroth G; Neumann M; Hofmann WK; Nolte F; Nowak D
    Br J Haematol; 2021 Mar; 192(5):879-891. PubMed ID: 33486765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCF4 promotes erythroid development.
    In 't Hout FEM; van Duren J; Monteferrario D; Brinkhuis E; Mariani N; Westers TM; Chitu D; Nikoloski G; van de Loosdrecht AA; van der Reijden BA; Jansen JH; Huls G
    Exp Hematol; 2019 Jan; 69():17-21.e1. PubMed ID: 30315825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest.
    Gañán-Gómez I; Wei Y; Yang H; Pierce S; Bueso-Ramos C; Calin G; Boyano-Adánez Mdel C; García-Manero G
    PLoS One; 2014; 9(4):e93404. PubMed ID: 24690917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors.
    Tehranchi R; Fadeel B; Forsblom AM; Christensson B; Samuelsson J; Zhivotovsky B; Hellstrom-Lindberg E
    Blood; 2003 Feb; 101(3):1080-6. PubMed ID: 12393561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
    Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
    Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Dostalova Merkerova M; Krejcik Z; Votavova H; Belickova M; Vasikova A; Cermak J
    Eur J Hum Genet; 2011 Mar; 19(3):313-9. PubMed ID: 21150891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulation of microRNAs in myelodysplastic syndrome.
    Rhyasen GW; Starczynowski DT
    Leukemia; 2012 Jan; 26(1):13-22. PubMed ID: 21852786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction.
    Fontenay-Roupie M; Bouscary D; Guesnu M; Picard F; Melle J; Lacombe C; Gisselbrecht S; Mayeux P; Dreyfus F
    Br J Haematol; 1999 Aug; 106(2):464-73. PubMed ID: 10460607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
    Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.